207 related articles for article (PubMed ID: 17845685)
1. Nitrofuran-based regimens for the eradication of Helicobacter pylori infection.
Buzás GM; Józan J
J Gastroenterol Hepatol; 2007 Oct; 22(10):1571-81. PubMed ID: 17845685
[TBL] [Abstract][Full Text] [Related]
2. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Buzás GM; Józan J
Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
[TBL] [Abstract][Full Text] [Related]
3. Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
[TBL] [Abstract][Full Text] [Related]
4. One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.
Lu H; Zhang DZ; Hu PJ; Li ZS; Lu XH; Fang XC; Xiao SD
Aliment Pharmacol Ther; 2001 Dec; 15(12):1975-9. PubMed ID: 11736729
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of furazolidone- and amoxicillin-based quadruple therapy for
Zhang YW; Hu WL; Cai Y; Zheng WF; Du Q; Kim JJ; Kao JY; Dai N; Si JM
World J Gastroenterol; 2018 Oct; 24(40):4596-4605. PubMed ID: 30386109
[TBL] [Abstract][Full Text] [Related]
6. Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability.
Luther J; Higgins PD; Schoenfeld PS; Moayyedi P; Vakil N; Chey WD
Am J Gastroenterol; 2010 Jan; 105(1):65-73. PubMed ID: 19755966
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Helicobacter pylori eradication therapies: a single centre observational study.
Beales IL
BMC Gastroenterol; 2001; 1():7. PubMed ID: 11545677
[TBL] [Abstract][Full Text] [Related]
8. First-line eradication of H pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2004.
Buzás GM; Józan J
World J Gastroenterol; 2006 Sep; 12(33):5311-9. PubMed ID: 16981260
[TBL] [Abstract][Full Text] [Related]
9. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
10. Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.
Qasim A; Sebastian S; Thornton O; Dobson M; McLoughlin R; Buckley M; O'Connor H; O'Morain C
Aliment Pharmacol Ther; 2005 Jan; 21(1):91-6. PubMed ID: 15644050
[TBL] [Abstract][Full Text] [Related]
11. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
Gisbert JP; Fuentes J; Carpio D; Tito L; Guardiola J; Tomas A; Olivares D; Calvet X
Aliment Pharmacol Ther; 2005 May; 21(10):1249-53. PubMed ID: 15882246
[TBL] [Abstract][Full Text] [Related]
12. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.
Tong JL; Ran ZH; Shen J; Xiao SD
J Clin Pharm Ther; 2009 Feb; 34(1):41-53. PubMed ID: 19125902
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of triple versus quadruple furazolidone-based eradication regimens for Helicobacter pylori infection].
Lü Z; Xie Y; Lü N; Zhou H; Liu Z; Zhu X; Chen Y; He X; Liu D; Ma J
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(8):572-5. PubMed ID: 24762683
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis.
Xin Y; Manson J; Govan L; Harbour R; Bennison J; Watson E; Wu O
BMC Gastroenterol; 2016 Jul; 16(1):80. PubMed ID: 27460211
[TBL] [Abstract][Full Text] [Related]
15. Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection.
Hojo M; Miwa H; Nagahara A; Sato N
Scand J Gastroenterol; 2001 Jul; 36(7):690-700. PubMed ID: 11444467
[TBL] [Abstract][Full Text] [Related]
16. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
Gisbert JP; Gonzalez L; Calvet X
Helicobacter; 2005 Jun; 10(3):157-71. PubMed ID: 15904473
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
18. Quadruple therapy with medications containing either rufloxacin or furazolidone as a rescue regimen in the treatment of Helicobacter pylori-infected dyspepsia patients: a randomized pilot study.
Gu LY; Lin WW; Lu H; Chen XY; Ge ZZ; Li XB
Helicobacter; 2011 Aug; 16(4):284-8. PubMed ID: 21762267
[TBL] [Abstract][Full Text] [Related]
19. Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease.
Ghadir MR; Shafaghi A; Iranikhah A; Pakdin A; Joukar F; Mansour-Ghanaei F
Turk J Gastroenterol; 2011 Feb; 22(1):1-5. PubMed ID: 21480103
[TBL] [Abstract][Full Text] [Related]
20. Tetracycline- and furazolidone-containing quadruple regimen as rescue treatment for Helicobacter pylori infection: a single center retrospective study.
Zhang Y; Gao W; Cheng H; Zhang X; Hu F
Helicobacter; 2014 Oct; 19(5):382-6. PubMed ID: 24849129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
